Protect your eyes,
one sip at a time.
Revolutionizing ocular health for digital device users. The world's first ready-to-drink functional beverage for eye health — co-developed by an optometrist and an ophthalmologist.
Recent press coverage for The Eye Drink.
Our eyes weren't built for screens.
Screen staring drops blink rate 80%+, leading to rapid tear evaporation and chronic Dry Eye Syndrome.
High-energy artificial blue light penetrates deep into the eye, damaging retinal cells and accelerating early-onset macular degeneration.
Blurred vision, premature presbyopia, severe headaches, and neck pain.
"Eye drops are temporary. Pills are forgotten. The digital age requires a proactive, daily defense."
Targeted protection you actually remember to take.
Counteracts blue light damage and enhances visual performance.
Up to 50% juice plus hydration boosters to reduce dry eye fatigue.
On-the-go accessibility for professionals, students, and gamers.
Retails at $3.75/bottle. Flavors: Magical Citrus, Strawberry Lemonade, Mango Strawberry.
Note for Jorge: the pitch deck's slide design shows $3.75/bottle, but its embedded file metadata says $4.50 — worth confirming the correct current price before this goes external.
Co-developed by an optometrist and an ophthalmologist.
Dr. Roger L. Wu (Optometrist) and Dr. Garlan Lo (Ophthalmologist) co-developed the formula, backed by AREDS2 clinical studies.
$8.5B US TAM at the intersection of two categories.
"We are capturing a blue-ocean space: the world's first ready-to-drink intersection of supplements and daily functional beverages."
High innovation. Specialized eye health. No direct competitor.
Functional gum & mints — high innovation, general wellness. Drawback: lacks specialized digital eye strain protection.
Basic innovation, general wellness. Drawback: no specific focus on eye health.
Basic innovation, specialized eye health. Drawback: requires daily pill intake, reducing compliance.
High Innovation × Specialized Eye Health = Category of One
The path to market leadership, 2026–2028.
Official DTC & Amazon launch. First-year revenue target $1.7M. Subscription model. Initial retail pharmacies.
Expansion into major national retailers (Target, Whole Foods, CVS). Broaden line with eye-health shots. B2B corporate wellness programs.
International pilot sales (Canada & UK). Secure Series A for supply chain optimization.
$20M+ projected revenue by Year 5.
A highly scalable, high-margin consumable product with recurring revenue built into its daily-use model.
Backed by the fund's full 8-pillar platform.
Separately from CPG Life Fund's own $1M–$3.5M check, The Eye Drink's pitch deck describes a standalone brand-level raise: $5,000,000 investment needed for a 25% equity stake at a $15,000,000 valuation, with a projected 2.01-year time to ROI. This is the brand's own fundraise terms, not CPG Life Fund's investment terms — shown here for full transparency.
See the Full Fund Deck
The Eye Drink is one of six brands inside CPG Life Fund I. See the full investment thesis and portfolio.
View Investor Deck →Press & Brand Inquiries
Interview requests, product samples, and brand assets for The Eye Drink.
Contact Us →